Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial.

<h4>Background</h4>Blinding trachoma, caused by ocular infection with Chlamydia trachomatis, is targeted for global elimination by 2020. Knowledge of risk factors can help target control interventions.<h4>Methodology/principal findings</h4>As part of a cluster randomised cont...

Full description

Bibliographic Details
Published in:	PLoS Neglected Tropical Diseases
Main Authors:	Emma M Harding-Esch, Tansy Edwards, Harran Mkocha, Beatriz Munoz, Martin J Holland, Sarah E Burr, Ansumana Sillah, Charlotte A Gaydos, Dianne Stare, David C W Mabey, Robin L Bailey, Sheila K West, PRET Partnership
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2010-11-01
Online Access:	https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0000861&type=printable

Similar Items

Mass treatment with azithromycin for trachoma control: participation clusters in households.
by: Elizabeth N Ssemanda, et al.
Published: (2010-10-01)

Non-participation during azithromycin mass treatment for trachoma in The Gambia: heterogeneity and risk factors.
by: Tansy Edwards, et al.
Published: (2014-08-01)

Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study.
by: Emma Harding-Esch, et al.
Published: (2015-04-01)

Association between ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in The Gambia.
by: Sarah E Burr, et al.
Published: (2013-01-01)

Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
by: Emma M Harding-Esch, et al.
Published: (2013-01-01)

A randomized trial of two coverage targets for mass treatment with azithromycin for trachoma.
by: Sheila K West, et al.
Published: (2013-01-01)

Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
by: Emma M Harding-Esch, et al.
Published: (2009-12-01)

Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.
by: Matthew J Burton, et al.
Published: (2010-10-01)

Evidence for contamination with C. trachomatis in the household environment of children with active Trachoma: A cross-sectional study in Kongwa, Tanzania.
by: Sheila K West, et al.
Published: (2019-12-01)

Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area
by: Sheila K. West, et al.
Published: (2018-02-01)

Treating village newcomers and travelers for trachoma: Results from ASANTE cluster randomized trial.
by: Sheila K West, et al.
Published: (2017-01-01)

Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia
by: Sarah E Burr, et al.

Diagnostic accuracy of a prototype point-of-care test for ocular Chlamydia trachomatis under field conditions in The Gambia and Senegal.
by: Emma M Harding-Esch, et al.
Published: (2011-08-01)

Household willingness to pay for azithromycin treatment for trachoma control in the United Republic of Tanzania
by: Frick Kevin D., et al.
Published: (2003-01-01)

Azithromycin mass treatment for trachoma control: risk factors for non-participation of children in two treatment rounds.
by: Elizabeth N Ssemanda, et al.
Published: (2012-01-01)

Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau.
by: Anna R Last, et al.
Published: (2014-06-01)

CT694 and pgp3 as serological tools for monitoring trachoma programs.
by: E Brook Goodhew, et al.
Published: (2012-01-01)

Gender differences in trachomatous scarring prevalence in a formerly trachoma hyperendemic district in Tanzania.
by: Meraf A Wolle, et al.
Published: (2024-01-01)

Gender differences in trachomatous scarring prevalence in a formerly trachoma hyperendemic district in Tanzania
by: Meraf A. Wolle, et al.
Published: (2024-01-01)

Comparison of two approaches to measuring clean faces as part of the facial cleanliness component of the SAFE trachoma elimination strategy.
by: Sheila K West, et al.
Published: (2024-04-01)

Correction: Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity
by: Fengchen Liu, et al.
Published: (2013-07-01)

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
by: Chrissy H Roberts, et al.
Published: (2014-03-01)

Baseline trachoma prevalence in Guinea: Results of national trachoma mapping in 31 health districts.
by: André Géopogui, et al.
Published: (2018-06-01)

Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania.
by: Luis Carlos Cajas-Monson, et al.
Published: (2011-03-01)

Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma
by: Fraser-Hurt Nicole, et al.
Published: (2001-01-01)

Trachomatous scarring among children in a formerly hyper-endemic district of Tanzania.
by: Jacob T Cox, et al.
Published: (2017-12-01)

Mapping the global distribution of trachoma
by: Sarah Polack, et al.
Published: (2005-12-01)

Chlamydia trachomatis ompA variants in trachoma: what do they tell us?
by: Aura A Andreasen, et al.
Published: (2008-09-01)

Trachoma and Ocular Chlamydial Infection in the Era of Genomics
by: Tamsyn Derrick, et al.
Published: (2015-01-01)

The SAFE strategy for trachoma control: using operational research for policy, planning and implementation
by: Emerson Paul M, et al.
Published: (2006-01-01)

Detection of trachoma using machine learning approaches.
by: Damien Socia, et al.
Published: (2022-12-01)

Impact of personal protective equipment on the clarity of vision among trachoma survey graders and trichiasis surgeons in the context of COVID-19
by: Michaela Kelly, et al.
Published: (2023-06-01)

The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up.
by: Nicholas C Grassly, et al.
Published: (2008-01-01)

Characterizing trachoma elimination using serology
by: Everlyn Kamau, et al.
Published: (2025-07-01)

Trachoma and Yaws: Common Ground?
by: Anthony W Solomon, et al.
Published: (2015-12-01)

Assessment of a Novel Approach to Identify Trichiasis Cases Using Community Treatment Assistants in Tanzania.
by: Gregory S Greene, et al.
Published: (2015-12-01)

Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana
by: Solomon Anthony W., et al.
Published: (2001-01-01)

Trachoma in Western Equatoria State, Southern Sudan: implications for national control.
by: Lucia W Kur, et al.
Published: (2009-07-01)

Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection?
by: Nkoyo Faal, et al.
Published: (2006-08-01)

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
Published: (2013-06-01)